tiprankstipranks
GeneDx Holdings (WGS)
NASDAQ:WGS
US Market

GeneDx Holdings (WGS) Financial Statements

356 Followers

GeneDx Holdings Financial Overview

GeneDx Holdings's market cap is currently ―. The company's EPS TTM is $-7.509; its P/E ratio is -1.27; GeneDx Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 53.30M$ 48.71M$ 43.14M-$ 83.23M
Gross Profit$ 25.26M$ 17.70M$ 13.49M-$ 13.55M
EBIT$ -43.51M$ -46.29M$ -57.65M-$ -76.84M
EBITDA-$ -46.16M$ -57.52M-$ -66.34M
Net Income Common Stockholders$ -42.29M$ -46.72M$ -60.99M-$ -77.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 114.30M$ 156.66M$ 214.04M$ 137.37M$ 191.36M
Total Assets$ 417.29M$ 476.39M$ 545.30M$ 490.91M$ 828.97M
Total Debt$ 6.05M$ 6.25M$ 6.25M$ 6.25M$ 77.98M
Net Debt$ -108.25M$ -150.41M$ -207.79M$ -131.12M$ -113.38M
Total Liabilities$ 163.03M$ 180.28M$ 216.83M$ 237.24M$ 267.68M
Stockholders Equity$ 254.26M$ 296.11M$ 328.47M$ 253.71M$ 561.29M
Cash Flow-
Free Cash Flow-$ -52.65M$ -55.56M-$ -92.64M
Operating Cash Flow$ -41.23M$ -53.52M$ -55.56M-$ -88.36M
Investing Cash Flow$ -27.13M$ -11.27M$ -462.00K-$ -4.28M
Financing Cash Flow$ -911.00K$ 7.39M$ 132.66M-$ -647.00K
Currency in USD

GeneDx Holdings Earnings and Revenue History

GeneDx Holdings Debt to Assets

GeneDx Holdings Cash Flow

GeneDx Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis